Report Detail

Medical Devices & Consumables Global Microbiome Therapies Market Growth (Status and Outlook) 2021-2026

  • RnM4284655
  • |
  • 08 February, 2021
  • |
  • Global
  • |
  • 118 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Devices & Consumables

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
  • 2.1.1 Global Microbiome Therapies Market Size 2016-2026
  • 2.1.2 Microbiome Therapies Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Microbiome Therapies Segment by Microbes
  • 2.2.1 Bacteria
  • 2.2.2 Bacteria
  • 2.2.3 Virus
  • 2.2.4 Others
  • 2.3 Microbiome Therapies Market Size by Microbes
  • 2.3.1 Global Microbiome Therapies Market Size CAGR by Microbes
  • 2.3.2 Global Microbiome Therapies Market Size Market Share by Microbes (2016-2021)
  • 2.4 Microbiome Therapies Segment by End User
  • 2.4.1 Testing Centres
  • 2.4.2 Research Labs
  • 2.4.3 Horticulture
  • 2.4.4 Others
  • 2.5 Microbiome Therapies Market Size by End User
  • 2.5.1 Global Microbiome Therapies Market Size CAGR by End User
  • 2.5.2 Global Microbiome Therapies Market Size Market Share by End User (2016-2021)
  • 3 Microbiome Therapies Market Size by Players

    • 3.1 Microbiome Therapies Market Size Market Share by Players
    • 3.1.1 Global Microbiome Therapies Revenue by Players (2019-2021E)
  • 3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Microbiome Therapies Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion
  • 4 Microbiome Therapies by Regions

    • 4.1 Microbiome Therapies Market Size by Regions (2016-2021)
    • 4.2 Americas Microbiome Therapies Market Size Growth (2016-2021)
    • 4.3 APAC Microbiome Therapies Market Size Growth (2016-2021)
    • 4.4 Europe Microbiome Therapies Market Size Growth (2016-2021)
    • 4.5 Middle East & Africa Microbiome Therapies Market Size Growth (2016-2021)

    5 Americas

    • 5.1 Americas Microbiome Therapies Market Size by Country (2016-2021)
    • 5.2 Americas Microbiome Therapies Market Size by Microbes (2016-2021)
    • 5.3 Americas Microbiome Therapies Market Size by End User (2016-2021)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil

    6 APAC

    • 6.1 APAC Microbiome Therapies Market Size by Region (2016-2021)
    • 6.2 APAC Microbiome Therapies Market Size by Microbes (2016-2021)
    • 6.3 APAC Microbiome Therapies Market Size by End User (2016-2021)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia

    7 Europe

    • 7.1 Europe Microbiome Therapies by Country (2016-2021)
    • 7.2 Europe Microbiome Therapies Market Size by Microbes (2016-2021)
    • 7.3 Europe Microbiome Therapies Market Size by End User (2016-2021)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia

    8 Middle East & Africa

    • 8.1 Middle East & Africa Microbiome Therapies by Region (2016-2021)
    • 8.2 Middle East & Africa Microbiome Therapies Market Size by Microbes (2016-2021)
    • 8.3 Middle East & Africa Microbiome Therapies Market Size by End User (2016-2021)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries

    9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends
  • 10 Global Microbiome Therapies Market Forecast

    • 10.1 Global Microbiome Therapies Forecast by Regions (2021-2026)
    • 10.1.1 Global Microbiome Therapies Forecast by Regions (2021-2026)
  • 10.1.2 Americas Microbiome Therapies Forecast
  • 10.1.3 APAC Microbiome Therapies Forecast
  • 10.1.4 Europe Microbiome Therapies Forecast
  • 10.1.5 Middle East & Africa Microbiome Therapies Forecast
  • 10.2 Americas Microbiome Therapies Forecast by Countries (2021-2026)
  • 10.2.1 United States Microbiome Therapies Market Forecast
  • 10.2.2 Canada Microbiome Therapies Market Forecast
  • 10.2.3 Mexico Microbiome Therapies Market Forecast
  • 10.2.4 Brazil Microbiome Therapies Market Forecast
  • 10.3 APAC Microbiome Therapies Forecast by Region (2021-2026)
  • 10.3.1 China Microbiome Therapies Market Forecast
  • 10.3.2 Japan Microbiome Therapies Market Forecast
  • 10.3.3 Korea Microbiome Therapies Market Forecast
  • 10.3.4 Southeast Asia Microbiome Therapies Market Forecast
  • 10.3.5 India Microbiome Therapies Market Forecast
  • 10.3.6 Australia Microbiome Therapies Market Forecast
  • 10.4 Europe Microbiome Therapies Forecast by Country (2021-2026)
  • 10.4.1 Germany Microbiome Therapies Market Forecast
  • 10.4.2 France Microbiome Therapies Market Forecast
  • 10.4.3 UK Microbiome Therapies Market Forecast
  • 10.4.4 Italy Microbiome Therapies Market Forecast
  • 10.4.5 Russia Microbiome Therapies Market Forecast
  • 10.5 Middle East & Africa Microbiome Therapies Forecast by Region (2021-2026)
  • 10.5.1 Egypt Microbiome Therapies Market Forecast
  • 10.5.2 South Africa Microbiome Therapies Market Forecast
  • 10.5.3 Israel Microbiome Therapies Market Forecast
  • 10.5.4 Turkey Microbiome Therapies Market Forecast
  • 10.5.5 GCC Countries Microbiome Therapies Market Forecast
  • 10.6 Global Microbiome Therapies Forecast by Microbes (2021-2026)
  • 10.8 Global Microbiome Therapies Forecast by End User (2021-2026)
  • 11 Key Players Analysis

    • 11.1 uBiome
    • 11.1.1 uBiome Company Information
  • 11.1.2 uBiome Microbiome Therapies Product Offered
  • 11.1.3 uBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.1.4 uBiome Main Business Overview
  • 11.1.5 uBiome Latest Developments
  • 11.2 Evolve BioSystems
  • 11.2.1 Evolve BioSystems Company Information
  • 11.2.2 Evolve BioSystems Microbiome Therapies Product Offered
  • 11.2.3 Evolve BioSystems Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.2.4 Evolve BioSystems Main Business Overview
  • 11.2.5 Evolve BioSystems Latest Developments
  • 11.3 Indigo Agriculture
  • 11.3.1 Indigo Agriculture Company Information
  • 11.3.2 Indigo Agriculture Microbiome Therapies Product Offered
  • 11.3.3 Indigo Agriculture Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.3.4 Indigo Agriculture Main Business Overview
  • 11.3.5 Indigo Agriculture Latest Developments
  • 11.4 Pivot Bio
  • 11.4.1 Pivot Bio Company Information
  • 11.4.2 Pivot Bio Microbiome Therapies Product Offered
  • 11.4.3 Pivot Bio Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.4.4 Pivot Bio Main Business Overview
  • 11.4.5 Pivot Bio Latest Developments
  • 11.5 Concentric Ag
  • 11.5.1 Concentric Ag Company Information
  • 11.5.2 Concentric Ag Microbiome Therapies Product Offered
  • 11.5.3 Concentric Ag Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.5.4 Concentric Ag Main Business Overview
  • 11.5.5 Concentric Ag Latest Developments
  • 11.6 Epibiome
  • 11.6.1 Epibiome Company Information
  • 11.6.2 Epibiome Microbiome Therapies Product Offered
  • 11.6.3 Epibiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.6.4 Epibiome Main Business Overview
  • 11.6.5 Epibiome Latest Developments
  • 11.7 CosmosID
  • 11.7.1 CosmosID Company Information
  • 11.7.2 CosmosID Microbiome Therapies Product Offered
  • 11.7.3 CosmosID Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.7.4 CosmosID Main Business Overview
  • 11.7.5 CosmosID Latest Developments
  • 11.8 Human Longevity
  • 11.8.1 Human Longevity Company Information
  • 11.8.2 Human Longevity Microbiome Therapies Product Offered
  • 11.8.3 Human Longevity Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.8.4 Human Longevity Main Business Overview
  • 11.8.5 Human Longevity Latest Developments
  • 11.9 Ajinomoto Cambrooke
  • 11.9.1 Ajinomoto Cambrooke Company Information
  • 11.9.2 Ajinomoto Cambrooke Microbiome Therapies Product Offered
  • 11.9.3 Ajinomoto Cambrooke Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.9.4 Ajinomoto Cambrooke Main Business Overview
  • 11.9.5 Ajinomoto Cambrooke Latest Developments
  • 11.10 AnimalBiome
  • 11.10.1 AnimalBiome Company Information
  • 11.10.2 AnimalBiome Microbiome Therapies Product Offered
  • 11.10.3 AnimalBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021)
  • 11.10.4 AnimalBiome Main Business Overview
  • 11.10.5 AnimalBiome Latest Developments
  • 12 Research Findings and Conclusion

    According to this latest study, the 2021 growth of Microbiome Therapies will have significant change from previous year. By the most conservative estimates of global Microbiome Therapies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Microbiome Therapies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
    This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome Therapies market by product type, application, key players and key regions and countries.

    Segmentation by microbes: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

    Bacteria

    Fungi

    Virus

    Others

    Segmentation by end user: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

    Testing Centres

    Research Labs

    Horticulture

    Others

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

    UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

    uBiome

    Evolve BioSystems

    Indigo Agriculture

    Pivot Bio

    Concentric Ag

    Epibiome

    CosmosID

    Human Longevity

    Ajinomoto Cambrooke

    AnimalBiome


    Summary:
    Get latest Market Research Reports on Microbiome Therapies. Industry analysis & Market Report on Microbiome Therapies is a syndicated market report, published as Global Microbiome Therapies Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Microbiome Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,524.74
    5,049.48
    2,926.48
    5,852.96
    378,689.50
    757,379.00
    255,726.80
    511,453.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report